Coronary Artery Disease and The Evolution of Angioplasty Devices (Paperback, 1st ed. 2020)

, , ,
In this concise but authoritative book, the authors take the reader through the epidemiology, risk factors and the basic mechanism of coronary artery disease. In addition, they explain how coronary microvascular dysfunction can lead to angina, even after successful angioplasty following a heart attack. The methods for diagnosis and the options for treatment are explained, ending with a discussion of the evolution of coronary angioplasty from balloon catheters to novel, fully resorbable polymeric drug eluting stents. Enclosed is a list of currently available commercial devices, as well as a listing of experimental products under research and development, so that readers can appreciate the serious nature of this disease and have an understanding of how the medical device sector is attempting to address this major healthcare problem. Globally in 2010, ischemic heart disease was the cause of 13.3% of all deaths. In the US alone, the direct medical costs from coronary artery disease and stroke are currently estimated to be $126 billion per year, and are expected to rise to $309 billion by 2035.

R1,839

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles18390
Mobicred@R172pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 10 - 15 working days



Product Description

In this concise but authoritative book, the authors take the reader through the epidemiology, risk factors and the basic mechanism of coronary artery disease. In addition, they explain how coronary microvascular dysfunction can lead to angina, even after successful angioplasty following a heart attack. The methods for diagnosis and the options for treatment are explained, ending with a discussion of the evolution of coronary angioplasty from balloon catheters to novel, fully resorbable polymeric drug eluting stents. Enclosed is a list of currently available commercial devices, as well as a listing of experimental products under research and development, so that readers can appreciate the serious nature of this disease and have an understanding of how the medical device sector is attempting to address this major healthcare problem. Globally in 2010, ischemic heart disease was the cause of 13.3% of all deaths. In the US alone, the direct medical costs from coronary artery disease and stroke are currently estimated to be $126 billion per year, and are expected to rise to $309 billion by 2035.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Springer Nature Switzerland AG

Country of origin

Switzerland

Series

SpringerBriefs in Materials

Release date

May 2020

Availability

Expected to ship within 10 - 15 working days

First published

2020

Authors

, , ,

Dimensions

235 x 155mm (L x W)

Format

Paperback

Pages

66

Edition

1st ed. 2020

ISBN-13

978-3-03-042442-8

Barcode

9783030424428

Categories

LSN

3-03-042442-1



Trending On Loot